SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000014272-20-000168
Filing Date
2020-05-07
Accepted
2020-05-07 09:54:07
Documents
88
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmy-20200331x10q.htm   iXBRL 10-Q 2305761
2 EXHIBIT 31.A bmyex31a20200331.htm EX-31.A 11661
3 EXHIBIT 31.B bmyex31b20200331.htm EX-31.B 11834
4 EXHIBIT 32.A bmyex32a20200331.htm EX-32.A 4587
5 EXHIBIT 32.B bmyex32b20200331.htm EX-32.B 4546
  Complete submission text file 0000014272-20-000168.txt   11423776

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20200331.xsd EX-101.SCH 61785
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20200331_cal.xml EX-101.CAL 120913
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20200331_def.xml EX-101.DEF 308213
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20200331_lab.xml EX-101.LAB 876445
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20200331_pre.xml EX-101.PRE 507207
58 EXTRACTED XBRL INSTANCE DOCUMENT bmy-20200331x10q_htm.xml XML 2538522
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 20854919
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences